Exhibit 99.1
| ASX ANNOUNCEMENT | 17 February 2025 |
Notice Under Section 708A(5)(e) of the Corporations Act
This notice is given by Alterity Therapeutics Limited ACN 080 699 065 (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), under section 708A(5)(e) of the Corporations Act 2001 (Cth) (Corporations Act).
| Details of securities issued | |
| Type: | Shares |
| Class/Description: | Fully paid ordinary shares |
| ASX Code: | ATH |
| Date of Issue: | 17 February 2025 |
| Number Issued: | 1,165,841,830 |
The Company gives notice pursuant to section 708A(5)(e) of the Corporations Act that:
| 1. | the Company issued the Shares without disclosure under Part 6D.2 of the Corporations Act; |
| 2. | as at the date of this notice, the Company has complied with: |
| (i) | the provisions of Chapter 2M of the Corporations Act as they apply to the Company; and |
| (ii) | sections 674 and 674A of the Corporations Act; and |
| 3. | as at the date of this notice there is no information to be disclosed which is ‘excluded information’ (as defined in sections 708A(7) and 708A(8) of the Corporations Act) which is required to be disclosed by the Company. |
| /s/ Abby Macnish Niven | |
| Abby Macnish Niven |
Company Secretary
Alterity Therapeutics Limited ACN 080 699 065
Level 14, 350 Collins Street, Melbourne, Victoria 3000 Australia
www.alteritytherapeutics.com